Merit Medical Systems, Inc., commonly referred to as Merit Medical, is a leading global provider of medical devices headquartered in the United States. Founded in 1987, the company has established a strong presence in key operational regions, including North America, Europe, and Asia. Specialising in interventional medicine, Merit Medical focuses on areas such as cardiology, radiology, and pain management. The company is renowned for its innovative core products, including catheter systems, access devices, and fluid management solutions, which are designed to enhance patient outcomes and streamline clinical procedures. Merit Medical's commitment to quality and innovation has positioned it as a trusted partner in the healthcare industry, with notable achievements in expanding its product portfolio and global reach.
How does Merit Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Merit Medical's score of 38 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Merit Medical reported total carbon emissions of approximately 17,656,000 kg CO2e. This figure includes 3,072,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 14,584,000 kg CO2e from Scope 2 emissions, which are indirect emissions from the generation of purchased electricity, steam, heating, and cooling. Notably, there were no reported Scope 3 emissions for the year. Comparatively, in 2022, the company recorded total emissions of about 17,239,000 kg CO2e, with Scope 1 emissions at 3,101,000 kg CO2e and Scope 2 emissions at 17,795,000 kg CO2e. This indicates a slight increase in total emissions year-on-year. Merit Medical has not disclosed any specific reduction targets or initiatives as part of their climate commitments. However, they are actively monitoring and reporting their emissions data, which is a crucial step in understanding and managing their carbon footprint. The absence of Scope 3 emissions reporting suggests a focus on direct and indirect emissions from energy use, but further commitments or targets have not been specified.
Access structured emissions data, company-specific emission factors, and source documents
2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|
Scope 1 | 2,995,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Scope 2 | 18,405,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | - | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Merit Medical is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.